Riskpilot← Back to searchSign inGet full accessNORSK HELSEKLINIKK AS
ASActiveOrg 984921896Kalkfjellet 12, 1387 AskerOther human health activities n.e.c. · NACE 8699Est. 20020 employees
Revenue 2024
NOK 217K
+275% vs 2023
EBITDA margin
79.6%
+346% vs 2023
Equity ratio
65.1%
Financial strength
Net profit 2024
NOK 173K
+345% vs 2023
| Revenue | NOK 217K | +275% |
| EBITDA | NOK 173K | +346% |
| Net profit | NOK 173K | +345% |
| Total assets | NOK 363K | +119% |
| Equity | NOK 236K | +274% |
| Employees | 0 | — |
Legal name
NORSK HELSEKLINIKK AS
Org number
984921896
Legal form
Aksjeselskap
NACE code
8699 · Other human health activities n.e.c.
Founded
7. oktober 2002
Share capital
NOK 100 000
Employees
0
VAT registered
Yes
Audit selected
No
Last report
2024-12-31
Financial year
January – December
Signatory rights
Styrets leder alene eller daglig leder alene.
Company purpose
1) drive klinisk utprøving av behandlingsmetoder og legemidler i egen regi og i samarbeid med farmasøytisk industri 2) drive forebyggende helsevirkosmhet innen vektreduksjon, kosthold, hjertekarsykdom, røykeavvenning og lungesykdommer 3) drive undervisning av helsearbeidere i hedmark og generell helse opplysning i regi av hedmark helseforsknings forening (hhff) 4) evt. Selge helsetjenester til bedrifter, sykehus, farmasøytisk industri, andre, samt hva hermed står i forbindelse, herunder å delta i andre selskpaer med lignende virksomhet.
Address
Kalkfjellet 12, 1387 Asker
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Revenue | 81 | 53 | 29 | 58 | 217 |
| Staff expenses | −0 | −42 | −0 | −0 | −0 |
| EBITDA | 59 | −7 | −5 | 39 | 173 |
| Depreciation & amort. | −3 | −0 | −0 | −0 | −0 |
| EBIT | 57 | −7 | −5 | 39 | 173 |
| Net financials | 0 | −0 | −0 | 0 | 0 |
| Profit before tax | 57 | −7 | −5 | 39 | 173 |
| Tax | −0 | −0 | −0 | −0 | −0 |
| Net profit | 57 | −7 | −5 | 39 | 173 |
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Total assets | 200 | 152 | 128 | 166 | 363 |
| Equity | 36 | 30 | 24 | 63 | 236 |
| Long-term debt | 0 | 0 | 0 | 0 | 0 |
| Short-term debt | 164 | 123 | 103 | 102 | 127 |
| Total debt | 164 | 123 | 103 | 102 | 127 |
EBITDA margin
79.6%
This company
15.8%
Market median
+404% vs market
20202024
Equity ratio
65.1%
This company
38.2%
Market median
+70% vs market
20202024
Return on equity
73.2%
This company
18.4%
Market median
+298% vs market
20202024
Net profit margin
79.6%
This company
8.1%
Market median
+883% vs market
20202024
Asset turnover
0.60×
This company
1.12×
Market median
-46% vs market
20202024
Debt / equity
0.54×
This company
0.62×
Market median
+13% vs market
20202024
- Annual report 2024Filed via Brønnøysundsregistrene · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Brønnøysundsregistrene · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Brønnøysundsregistrene · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Brønnøysundsregistrene · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via Brønnøysundsregistrene · Period 2020-01-01 – 2020-12-31
| Name | Role | Member since |
|---|---|---|
| Current (1) | ||
CS Deputy Member | Deputy Member | 2004 |
| Name | Role | Member since |
|---|---|---|
| Current (1) | ||
| Chairman | 2004 | |
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of NORSK HELSEKLINIKK AS also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Cathrine Saxhaug | Deputy Member | 0 companies |
| Leidulv Solnør | Chairman | 0 companies |